If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcuity RM Group plc Regulatory News (ACRM)

Share Price Information for Acuity RM Group plc (ACRM)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £1.77m
ACRM Live PriceLast checked at - London Stock Exchange

Intraday Acuity RM Group plc Share Chart

New professional services agreement and order

10 Jun 2024 07:00

RNS Number : 6676R
Acuity RM Group PLC
10 June 2024
 

NON-REGULATORY

 

Acuity RM Group plc

("Acuity" or the "Group")

 

New professional services agreement and order

 

Acuity (AIM: ACRM), the software group, is delighted to announce that its subsidiary, Acuity Risk Management Ltd ("ARML"), which supplies the award-winning STREAMâ software platform for the Governance, Risk and Compliance ("GRC") market, together with associated consultancy services, has signed a new professional services agreement ("Agreement") with Sopra Steria.

 

ARML has worked successfully over the past two years with Sopra Steria and won some of Acuity's larger contracts. This move to a formal Agreement is a further indication that both parties see a future that is stronger when working in collaboration. Sopra Steria has 47,000 employees in nearly 30 countries around the world. It is a European leader in consulting, digital services and software development.

 

ARML also announces it has won a new contract in collaboration with Sopra, which is for consulting services, with further opportunities for upsell of STREAMâ to the end client which is the British Government.

 

 

Kerry Chambers, Chief Executive ARML, commented; "I am delighted to announce our Agreement with Sopra Steria. Whilst we have worked together for the past two years the Agreement demonstrates the confidence that the parties have in each other. This collaboration marks a significant milestone for Acuity Risk Management Ltd. We believe it will open more significant contract opportunities in the future."

 

 

For further information please contact:

 

 

Acuity RM Group plc

https://acuityrmgroup.com

Angus Forrest

+44 (0) 20 3582 0566

 

 

Note to Editors

Acuity RM Group plc

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning STREAM® software platform collects data about organisations to improve business decisions and management. It is used by around 70 organisations in markets including government, utilities, defence, broadcasting, manufacturing and healthcare.

 

The Company is focused on delivering long term, sustainable growth in shareholder value. In the short to medium term this is expected to come from organic growth and thereafter may also come from complementary acquisitions.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFIVRDIDIIS
12
Date   Source Headline
7th Jul 20261:53 pmPRNResult of General Meeting and Subscription
2nd Jul 202611:08 amPRNNotice of Annual General Meeting
29th Jun 20264:18 pmPRNFinal Results 2025 Investor Presentation via Investor Meet Company
29th Jun 20267:00 amPRNFinal Results
23rd Jun 20267:00 amPRNResult of Oversubscribed Retail Offer
17th Jun 20267:00 amPRNRetail Offer
16th Jun 20264:33 pmRNSFundraise of approximately £400,000
8th Jun 20267:00 amRNS-RContract Expansion
24th Apr 20267:00 amPRNTrading Statement
23rd Apr 20267:00 amPRNTrading Statement
27th Mar 20267:00 amPRNIssue of Equity
16th Mar 20267:00 amRNSProduct Launch
16th Mar 20267:00 amPRNProduct Launch
9th Mar 20267:00 amRNS-RA client’s experience of Acuity
24th Feb 20267:00 amRNS-RContract win
17th Feb 20267:00 amPRNContract
5th Feb 20262:35 pmPRNDirector/PDMR Shareholding
5th Feb 20261:17 pmPRNPDMR Shareholding
4th Feb 20267:00 amPRNHolding in Company
2nd Feb 20267:00 amPRNContract
15th Jan 20268:07 pmPRNHoldings in Company and Director Dealing
15th Jan 20267:00 amPRNStatement re Investor Presentation 10.00am 21 January
13th Jan 20267:00 amPRNTrading Statement
18th Nov 20258:47 amRNSHolding(s) in Company
17th Nov 20257:00 amPRNStatement re sale of investment
13th Nov 20254:06 pmPRNHolding(s) in Company
12th Nov 20257:00 amPRNDirectorate changes
21st Oct 20257:00 amRNS-RContract Win
7th Oct 20257:00 amPRNContract
22nd Sep 20257:00 amPRNIssue of Equity
16th Sep 20251:03 pmPRNHolding(s) in Company
5th Sep 20257:00 amPRNStatement re Investor presentation 10.00am 11 September
2nd Sep 20257:00 amPRNHalf-year Report
18th Aug 20257:00 amRNS-RFirst customer win for new product
30th Jul 20251:52 pmPRNResult of AGM
29th Jul 20257:00 amPRNIssue of Equity
11th Jul 202511:33 amPRNHolding(s) in Company
7th Jul 20254:09 pmPRNAnnual Report and Notice of AGM
7th Jul 202512:23 pmPRNHolding(s) in Company
7th Jul 20257:00 amPRNProduct Launch
4th Jul 202511:56 amPRNHolding(s) in Company
2nd Jul 20257:00 amPRNStatement re Final Results
30th Jun 20251:54 pmPRNIssue of Equity
26th Jun 20256:04 pmPRNHolding(s) in Company
25th Jun 20259:30 amRNSFinal Results
19th Jun 20253:22 pmPRNHolding(s) in Company
13th Jun 202510:30 amPRNStatement re Business and Directorate
21st May 20257:00 amPRNIssue of Equity
19th May 20259:45 amPRNIssue of Equity
19th May 20257:00 amPRNIssue of Equity
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.